<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Peter Doherty Institute for Infection &amp;amp; Immunity, Melbourne VIC 3000," exact="Australia" post="For correspondence: Dr Shailesh D. Pawar, ICMR-National Institute of"/>
 <result pre="Institute Compound, Acharya Donde Marg, Parel, Mumbai 400 012, Maharashtra," exact="India" post="e-mail: shaileshpawarniv@gmail.com ppub: 2019-111505486491received: 2018-5-03(C) , 2019This is an"/>
 <result pre="HPAI H5N1 viruses. Methods: Two HPAI H5N1 viruses isolated from" exact="India" post="were used in the study. Fluorescence-based NAI assay was"/>
 <result pre="has caused &amp;gt;159 outbreaks in poultry in different parts of" exact="India" post="since 2006, with the most recent outbreaks in Odisha"/>
 <result pre="and prophylaxis of influenza4; peramivir is licensed for use in" exact="the United States" post="of America5. Recently resistance to the NAIs oseltamivir and"/>
 <result pre="prophylaxis of influenza4; peramivir is licensed for use in the" exact="United States" post="of America5. Recently resistance to the NAIs oseltamivir and"/>
 <result pre="were isolated from outbreaks of HPAI H5N1 in poultry from" exact="the States" post="of Maharashtra and Tripura, India, respectively. The following amino"/>
 <result pre="Influenza and High Containment Laboratory, ICMR-National Institute of Virology, Pune," exact="India" post="from December 2015 to October 2016. Fluorescence-based neuraminidase inhibitor"/>
 <result pre="pathogenic influenza A (H5N1) viruses isolated from avian species in" exact="India" post="(2006-2015)Antiviral Res2018158143630125616 7OhDYHurtACA review of the antiviral susceptibility of"/>
</results>
